Sort
27,075 grants matching “cholesterol”
Endosome Dysfunction in Alzheimer's Disease
$741,201Ralph A. Nixon · New York University School Of Medicine · R01 · FY2020 · AG
The effects of orange juice compared with sugar-sweetened beverage on risk factors and metabolic processes associated with the development of cardiovascular disease and type 2 diabetes
$741,113Kimber Lee Stanhope · University Of California At Davis · R01 · FY2019 · HL
Reducing Risk Factors in Peripheral Arterial Disease
$741,097Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2006 · HL
Probing The Dark Matter of the Genome in the NHLBI Family Heart Study
$740,725Michael A Province · Washington University · R01 · FY2015 · HL
Improving treatment of cardiovascular risk factors in childhood cancer survivors
$740,451Eric Jessen Chow · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Sub Clinical Cardiovascular Disease in Youth (SEARCH CVD)
$740,338Dana Dabelea · University Of Colorado Denver · R01 · FY2010 · DK
A Novel Mouse Model of Obesity in Pregnancy
$740,296Thomas Jansson · University Of Texas Hlth Science Center · R24 · FY2014 · OD
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants
$740,154Markella V. Zanni · Massachusetts General Hospital · R01 · FY2018 · AI
DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
$740,115Robert Henry Knopp · University Of Washington · R01 · FY2008 · HL
CV RISK REDUCTION IN MINORITY PRESCHOOL CHILDREN
$740,054Columbia University Health Sciences · R01 · FY2000 · HL
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain
$739,802Elizabeth A Proctor · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · AG
Atheroprotective Gene Therapy
$739,701David A Dichek · University Of Washington · R01 · FY2019 · HL
Lifestyle Management of CKD in Obese Diabetic Patients
$739,433Mary A Sevick · New York University School Of Medicine · R01 · FY2016 · DK
Lifestyle Management of CKD in Obese Diabetic Patients
$739,433Mary A Sevick · New York University School Of Medicine · R01 · FY2015 · DK
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals
$739,365Pankaj Arora · University Of Alabama At Birmingham · R01 · FY2025 · HL
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
$739,261Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Personalized genetic profiles of risk and resilience in Alzheimer's and vascular diseases
$739,222Alexander M Kulminski · Duke University · R01 · FY2023 · AG
CV Benefits and Safety of Glucose-Lowering Therapies in Adults with Diabetes
$739,203Patrick J O'Connor · Healthpartners Institute · R01 · FY2017 · HL
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
$738,991Matthew Oetjens · Geisinger Clinic · R01 · FY2025 · HL
The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study
$738,831Danxia Yu · Vanderbilt University Medical Center · R01 · FY2023 · DK
Implementation Research: Translating the ABC's into HIV Care
$738,811Kevin Fiscella · University Of Rochester · U01 · FY2018 · HL
Early Life Adversity, Sleep, and Cardiovascular Risk in Black and White Men
$738,387Karen A Matthews · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
Balloon Angioplasty Inflation Device
$738,340Nick Rydberg · Minnesota Healthsolutions Corporation · R44 · FY2019 · AG
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
$738,253Matthew Oetjens · Geisinger Clinic · R01 · FY2023 · HL
Fetal Antecedents to Depression and Risk for CVD
$738,191Jill M Goldstein · Brigham And Women'S Hospital · R01 · FY2010 · MH